Sorry, you need to enable JavaScript to visit this website.
Skip to main content

In cooperation with law enforcement and regulatory agencies in the United States and Canada, the Federal Trade Commission will hold a press conference to announce deceptive advertising complaints it has filed against online peddlers of bogus cancer cures.

WHO: Lydia Parnes, Director,
FTC Bureau of Consumer Protection

Douglas Stearn, Director,
Division of Compliance Policy,
Office of Enforcement,
U.S. Food and Drug Administration

WHEN: Thursday, September 18, 2008, 11 a.m.
WHERE: Federal Trade Commission
600 Pennsylvania Ave., N.W., Room 432
Washington, DC

Reporters unable to attend the event can either call in or view the webcast on the day of the event.
PRESS CONTACT: FTC Office of Public Affairs